Skip to main content

Pathology and Staging

  • Chapter
  • First Online:
A Guide to Management of Urological Cancers

Abstract

Penile cancers have a heterogeneous distribution worldwide, ranging from age-standardised incidence of >2 per 100,000 in Africa, South America and South Asia to incidence of <0.5 per 100,000 in the Middle East and East Asia [1]. Penile cancer (PC) is an extremely uncommon disease with an incidence as low as 0.29/100,000 in the United States [2].The World Health Organization (WHO) estimated a total of 36,068 new cases in 2020 with an incidence of 0.8 per 100,000 men worldwide [3]. Penile squamous cell carcinoma (PSCC) is the fourth least common cancer by incidence and is classified under “rare tumour” as per the definition by the National Cancer Institute [4]. The incidence is higher in certain African and South American countries such as Uganda with an incidence of 4.4 per 100,000 and Paraguay with an incidence of 4.2 per 100,000 [2]. This heterogeneity is attributed to various risk factors such as socioeconomic status, history of penile injuries and inflammation, tobacco smoking, hygiene, genetic predisposition, the prevalence of practice of circumcision and human papillomavirus (HPV) infection [5, 6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bandini M, Ahmed M, Basile G, et al. A global approach to improving penile cancer care. Nat Rev Urol. 2022;19(4):231–9.

    Article  PubMed  Google Scholar 

  2. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159(4):1211–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. International Agency for Research on Cancer, WHO. Cancer today. GCO. 2020. http://gco.iarc.fr/today/home.

  4. National Cancer Institute. Definition of rare cancer. NCI Dictionary of Cancer Terms.

    Google Scholar 

  5. Douglawi A, Masterson TA. Penile cancer epidemiology and risk factors: a contemporary review. Curr Opin Urol. 2019;29(2):145–9.

    Article  PubMed  Google Scholar 

  6. Chaux A, Netto GJ, Rodríguez IM, et al. Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol. 2013;31(4):861–7.

    Article  PubMed  Google Scholar 

  7. Takiar R, Kumar S. Pattern of reproductive cancers in India. Asian Pac J Cancer Prev. 2014;15(2):599–603.

    Article  PubMed  Google Scholar 

  8. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents volume VIII. IARC Scientific Publications No. 155. Lyon: The International Agency for Research on Cancer; 2002.

    Google Scholar 

  9. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. Cancer incidence in five continents volume X. IARC Scientific Publications No. 164. Lyon: The International Agency for Research on Cancer; 2014.

    Google Scholar 

  10. Larke NL, Thomas SL, Dos Santos SI, Weiss HA. Male circumcision and penile cancer: a systematic review and meta-analysis. Cancer Causes Control. 2011;22(8):1097–110.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Pow-Sang MR, Ferreira U, Pow-Sang JM, Nardi AC, Destefano V. Epidemiology and natural history of penile cancer. Urology. 2010;761:S2.

    Article  Google Scholar 

  12. Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116(4):606–16.

    Article  CAS  PubMed  Google Scholar 

  13. Tseng HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001;12(3):267–77.

    Article  Google Scholar 

  14. Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993;85(1):19–24.

    Article  CAS  PubMed  Google Scholar 

  15. Van Howe RS, Hodges FM. The carcinogenicity of smegma: debunking a myth. J Eur Acad Dermatol Venereol. 2006;20(9):1046–54.

    Article  PubMed  Google Scholar 

  16. Schoen EJ, Oehrli M, Colby C, Machin G. The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics. 2000;105(3):E36.

    Article  CAS  PubMed  Google Scholar 

  17. Clouston D, Hall A, Lawrentschuk N. Penile lichen sclerosus (balanitis xerotica obliterans). BJU Int. 2011;108(Suppl 2):14–9.

    Article  PubMed  Google Scholar 

  18. Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet a radiation (PUVA) and ultraviolet B radiation. The photochemotherapy follow-up study. N Engl J Med. 1990;322(16):1093–7.

    Article  CAS  PubMed  Google Scholar 

  19. Harish K, Ravi R. The role of tobacco in penile carcinoma. Br J Urol. 1995;75(3):375–7.

    Article  CAS  PubMed  Google Scholar 

  20. Thuret R, Sun M, Budaus L, et al. A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis. Cancer Causes Control. 2013;24(1):71–9.

    Article  PubMed  Google Scholar 

  21. Koifman L, Vides AJ, Koifman N, Carvalho JP, Ornellas AA. Epidemiological aspects of penile cancer in Rio de Janeiro: evaluation of 230 cases. Int Braz J Urol. 2011;37(2):231–40.

    Article  PubMed  Google Scholar 

  22. Ulff-Møller CJ, Simonsen J, Frisch M. Marriage, cohabitation and incidence trends of invasive penile squamous cell carcinoma in Denmark 1978–2010. Int J Cancer. 2013;133(5):1173–9.

    Article  PubMed  Google Scholar 

  23. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS. 2006;20(12):1645–54.

    Article  PubMed  Google Scholar 

  24. D’Hauwers KWM, Depuydt CE, Bogers JJ, et al. Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium. Vaccine. 2012;30(46):6573–7.

    Article  PubMed  Google Scholar 

  25. Alemany L, Cubilla A, Halec G, et al. Role of human papillomavirus in penile carcinomas worldwide. Eur Urol. 2016;69(5):953–61.

    Article  PubMed  Google Scholar 

  26. Da Costa Nunes JF, Pires S, Chade DC. Human papillomavirus vaccination and prevention of intraepithelial neoplasia and penile cancer: review article. Curr Opin Urol. 2020;30(2):208–12.

    Article  PubMed  Google Scholar 

  27. Nordenvall C, Chang ET, Adami HO, Ye W. Cancer risk among patients with condylomata acuminata. Int J Cancer. 2006;119(4):888–93.

    Article  CAS  PubMed  Google Scholar 

  28. Hoekstra RJ, Trip EJ, ten Kate FJW, Horenblas S, Lock MT. Penile intraepithelial neoplasia: nomenclature, incidence and progression to malignancy in The Netherlands. Int J Urol. 2019;26(3):353–7.

    Article  PubMed  Google Scholar 

  29. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs—part a: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93–105.

    Article  PubMed  Google Scholar 

  30. Ingles DJ, Pierce Campbell CM, Messina JA, et al. Human papillomavirus virus (HPV) genotype-and age-specific analyses of external genital lesions among men in the HPV infection in men (HIM) study. J Infect Dis. 2015;211(7):1060–7.

    Article  PubMed  Google Scholar 

  31. Sudenga SL, Ingles DJ, Pierce Campbell CM, et al. Genital human papillomavirus infection progression to external genital lesions: the HIM study. Eur Urol. 2016;69(1):166–73.

    Article  PubMed  Google Scholar 

  32. Akogbe GO, Ajidahun A, Sirak B, et al. Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States. Int J Cancer. 2012;131(3):1–10.

    Article  Google Scholar 

  33. Fernández-Nestosa MJ, Guimerà N, Sanchez DF, et al. Human papillomavirus (HPV) genotypes in condylomas, intraepithelial neoplasia, and invasive carcinoma of the penis using laser capture microdissection (LCM)-PCR: a study of 191 lesions in 43 patients. Am J Surg Pathol. 2017;41(6):820–32.

    Article  PubMed  Google Scholar 

  34. Emmanuel A, Nettleton J, Watkin N, Berney DM. The molecular pathogenesis of penile carcinoma—current developments and understanding. Virchows Arch. 2019;475(4):397–405.

    Article  PubMed  Google Scholar 

  35. Steinestel J, Al Ghazal A, Arndt A, et al. The role of histologic subtype, p16INK4a expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma. BMC Cancer. 2015;15(1):1–9.

    Article  CAS  Google Scholar 

  36. Gewin L, Myers H, Kiyono T, Galloway DA. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 2004;18(18):2269–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age- related diseases and cancer. Recent Patents Inflamm Allergy Drug Discov. 2009;3(1):73–80.

    Article  CAS  Google Scholar 

  38. De Paula AAP, Motta ED, Alencar RDC, et al. The impact of cyclooxygenase-2 and vascular endothelial growth factor C immunoexpression on the prognosis of penile carcinoma. J Urol. 2012;187(1):134–40.

    Article  PubMed  Google Scholar 

  39. Greenhough A, Smartt HJM, Moore AE, et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30(3):377–86.

    Article  CAS  PubMed  Google Scholar 

  40. Poetsch M, Hemmerich M, Kakies C, et al. Alterations in the tumor suppressor gene p16 INK4A are associated with aggressive behavior of penile carcinomas. Virchows Arch. 2011;458(2):221–9.

    Article  CAS  PubMed  Google Scholar 

  41. Ferreux E, Lont AP, Horenblas S, et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol. 2003;201(1):109–18.

    Article  CAS  PubMed  Google Scholar 

  42. Lohneis P, Boral S, Kaufmann AM, et al. Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes. Virchows Arch. 2015;466(3):323–31.

    Article  PubMed  Google Scholar 

  43. Chu C, Yao K, Lu J, et al. Immunophenotypes based on the tumor immune microenvironment allow for unsupervised penile cancer patient stratification. Cancers (Basel). 2020;12(7):1–17.

    Article  Google Scholar 

  44. Ottenhof SR, Djajadiningrat RS, Thygesen HH, et al. The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma. Front Immunol. 2018;9:1253.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Hakenberg OW, Compérat E, Minhas S, Necchi A, Protzel C, Watkin N, Robinson R. EAU guidelines. Amsterdam: EAU Annual Congress; 2020.

    Google Scholar 

  46. Alkatout I, Naumann CM, Hedderich J, et al. Squamous cell carcinoma of the penis: predicting nodal metastases by histologic grade, pattern of invasion and clinical examination. Urol Oncol. 2011;29(6):774–81.

    Article  PubMed  Google Scholar 

  47. Schlenker B, Scher B, Tiling R, et al. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol. 2012;30(1):55–9.

    Article  PubMed  Google Scholar 

  48. Letendre J, Saad F, Lattouf JB. Penile cancer: what’s new? Curr Opin Support Palliat Care. 2011;5(3):185–91.

    Article  PubMed  Google Scholar 

  49. Petralia G, Villa G, Scardino E, et al. Stadiazione locale del tumore del pene con risonanza magnetica abbinata a test di farmacoinfusione intracavernosa (RM-TFI). Radiol Med. 2008;113(4):517–28.

    Article  CAS  PubMed  Google Scholar 

  50. Cubilla AL, Velazquez EF, Amin MB, Epstein J, Berney DM, Corbishley CM, Members of the ISUP Penile Tumor Panel. The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology. 2018;72:893–904.

    Article  PubMed  Google Scholar 

  51. Danakas AM, Bsirini C, Miyamoto H. The impact of routine frozen section assessment during penectomy on surgical margin status and long-term oncologic outcomes. Pathol Oncol Res. 2018;24(4):947–50.

    Article  PubMed  Google Scholar 

  52. The Royal College of Pathologist. Cancer datasets and tissue pathways. https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html.

  53. Corbishley C, Chaux A, Colecchia M, Cubilla AL, Shanks J, Velazquez EF, Watkin N, Srigley JR. Carcinoma of the penis and distal urethra histopathology reporting guide 1st edition. International collaboration on cancer reporting; Sydney, Australia. 2017. ISBN: 978-1-925687-05-7.

    Google Scholar 

  54. College of American Pathologist. Cancer protocol templates. https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates.

  55. Khalil MI, Kamel MH, Dhillon J, et al. What you need to know: updates in penile cancer staging. World J Urol. 2021;39(5):1413–9.

    Article  PubMed  Google Scholar 

  56. Brierley J. National Cancer Institute of Canada committee on cancer staging. The evolving TNM cancer staging system: an essential component of cancer care. CMAJ. 2006;174:155–6.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Sanchez DF, Fernandez-Nestosa MJ, Canete-Portillo S, Rodriguez I, Cubilla AL. What is new in the pathologic staging of penile carcinoma in the 8th edition of AJCC TNM model: rationale for changes with practical stage-by-stage category diagnostic considerations. Adv Anat Pathol. 2021;28(4):209–27.

    Article  CAS  PubMed  Google Scholar 

  58. Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018;73(4):560–9.

    Article  PubMed  Google Scholar 

  59. Cornejo KM, Rice-Stitt T, Wu CL. Updates in staging and reporting of genitourinary malignancies. Arch Pathol Lab Med. 2020;144(3):305–19.

    Article  PubMed  Google Scholar 

  60. Li ZS, Ornellas AA, Schwentner C, et al. A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer ChiCTR16008041 ChiCTR 11 medical and health sciences 1112 oncology and carcinogenesis. Cancer Commun. 2018;38(1):1–10.

    Article  Google Scholar 

  61. Leijte JAP, Gallee M, Antonini N, Horenblas S. Evaluation of current TNM classification of penile carcinoma. J Urol. 2008;180(3):933–8.

    Article  PubMed  Google Scholar 

  62. Sun M, Djajadiningrat RS, Alnajjar HM, et al. Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis. BJU Int. 2015;116(5):734–43.

    Article  PubMed  Google Scholar 

  63. Sali AP, Menon S, Murthy V, et al. A modified Histopathologic staging in penile squamous cell carcinoma predicts nodal metastasis and outcome better than the current AJCC staging. Am J Surg Pathol. 2020;44(8):1112–7.

    Article  PubMed  Google Scholar 

  64. Sali AP, Prakash G, de Cássio ZS, et al. A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma—a validation on an external data set. Histopathology. 2022;80(3):566–74.

    Article  PubMed  Google Scholar 

  65. Li ZS, Yao K, Chen P, et al. Modification of N staging systems for penile cancer: a more precise prediction of prognosis. Br J Cancer. 2015;112(11):1766–71.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL. New N staging system of penile cancer provides a better reflection of prognosis. J Urol. 2011;186(2):518–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yadav, S., Menon, S., Desai, S. (2023). Pathology and Staging. In: Singh, P., Nayak, B., Panaiyadiyan, S. (eds) A Guide to Management of Urological Cancers. Springer, Singapore. https://doi.org/10.1007/978-981-99-2341-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-2341-0_20

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-2340-3

  • Online ISBN: 978-981-99-2341-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics